airway management 3

135
Airway Management Airway Management Emergency Medicine Emergency Medicine Seminar Series Seminar Series

Upload: dang-thanh-tuan

Post on 25-May-2015

5.214 views

Category:

Health & Medicine


9 download

TRANSCRIPT

Page 1: Airway  Management 3

Airway ManagementAirway Management

Emergency Medicine Emergency Medicine

Seminar SeriesSeminar Series

Page 2: Airway  Management 3

Michael HaMichael HaSection of Emergency Medicine

4th year Resident

John SokalJohn SokalHealth Sciences Centre

12 years

Bob SweetlandBob SweetlandHealth Sciences Centre

15 years

Page 3: Airway  Management 3

CHURCHILL

ASHERN

PINE FALLS

April 25, 2002

Page 4: Airway  Management 3

April 26, 2002

STEINBACH

BOUNDARY TRAILS

Page 5: Airway  Management 3

May 2, 2002

BRANDON

KILLARNEY

PORTAGE

Page 6: Airway  Management 3

RUSSELL

DAUPHIN

SWAN RIVER

May 3, 2002

Page 7: Airway  Management 3

FLIN FLON

LYNN LAKE

THE PAS

May 14, 2002

Page 8: Airway  Management 3

eMEDiUMeMEDiUM

Emergency Medicine Emergency Medicine in the U of Min the U of M

emergency.mb.caemergency.mb.ca

Back

Page 9: Airway  Management 3

CAEP CAEP ACEP ACEP

Page 10: Airway  Management 3

CME ObjectivesCME Objectives

To discuss:

• the indications for intubation

• the approach to RSI

• capnometry

• bougies

Page 11: Airway  Management 3

Intubate?

RSI vs. Awake

Preparing for patient

Difficult BVM

Difficult Intubation

Capnography

Laryngoscopy Tips

Bougies

Lightwand - LMA

Preoxygenation

Pretreatment

O2 Delivery

Thiopental

Ketamine

Propofol

Succinylcholine

Rocuronium

Finish

Master

Page 12: Airway  Management 3

Intubation Indications

Is there a failure of

airway maintenance or protection?

Is there a failure of

ventilation or oxygenation?

What is the

anticipated clinical course?

Back

Page 13: Airway  Management 3

45 female

alcoholic beverages empty pill bottles

HR 125

BP 98/40

RR 20 GCS 8

O2Sats 100% (PRB)

no injuries

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

Page 14: Airway  Management 3

Cases60 VF

44 MVA

25 asthma

15 fall

28 bull

16pencil

40fire

22 TCA

54CRF

67HTN

51melena

45 overdose

Page 15: Airway  Management 3

AMI VF - defibrillated 3x

60 male IHD

HR 110

BP 68 / 40

RR 10

O2Sats 90% (BVM)

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

Page 16: Airway  Management 3

MVA MVA 100 kph kph

44 female

HR 130

BP 100 / 70

RR 28

O2Sats 99% (BVM)

GCS 6

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

Page 17: Airway  Management 3

SOB 2 days severe distress

HR 145

BP 98 / 42

RR 30

O2Sats 80% (PRB)

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

25 female asthma

cases

Page 18: Airway  Management 3

fell from treefell from tree

HR 110

BP 100 / 50

RR 20

O2Sats 99% (BVM)

GCS 8

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

15 15 female

cases

Page 19: Airway  Management 3

playing with bull blunt trauma

HR 130

BP 80 / 60

RR 28

O2Sats 99% (PRB)

abdomen rigid

pelvic fracture

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

28 male

Page 20: Airway  Management 3

pencil oropharynx 'buddy' pulled it out

HR 80

BP 115 / 60

RR 16

O2Sats 99% (room)

voice change

hematoma visible

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

16 male

Page 21: Airway  Management 3

house fire prolonged exposure

HR 115

BP 130 / 60

RR 28

O2Sats 96% (PRB)

singed facial hair

soot in mouth

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

40 female

Page 22: Airway  Management 3

ingestion amitryptyline quantity unknown

HR 145

BP 100 / 42

RR 14

O2Sats 99% (PRB)

GCS 8

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

22 22 female

Page 23: Airway  Management 3

on dialysis holiday respiratory distress

HR 115

BP 200 / 120

RR 36

O2Sats 88% (NRB)

peaked T's

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

54 male CRF DM

Page 24: Airway  Management 3

on ACE inhibitor oral angioedema

HR 85

BP 150 / 80

RR 20

O2Sats 99% (room)

slight stridor

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

67 female HTN

Page 25: Airway  Management 3

melena 2 days hematemesis

HR 165

BP 50 palpation

RR 28

O2Sats 92% (NRB)

vomiting red blood

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

51 male cirrhosis

Page 26: Airway  Management 3

HR 125

BP 180 / 100

RR 32

O2Sats 86% (NRB)

SOB over 3 days SOB over 3 days worsened overnightworsened overnight

Questions?

Indication?

Awake vs RSI?

LOAD?

Induction agent?

Paralytic agent?

cases

68 male CHF

Page 27: Airway  Management 3

Intubate?Intubate?

Custom Shows

Page 28: Airway  Management 3

45 female

alcoholic beverages empty pill bottles

Intubate?Intubate?

HR 125 BP 98/40

RR 20 GCS 8

O2Sats 100% (PRB)

no injuries

Indication?

Page 29: Airway  Management 3

Intubation Indications

Is there a failure of

airway maintenance or protection?

Page 30: Airway  Management 3

50 yo male

SOB over 2 days worsened overnight

HR 135 BP 150/90

RR 10

O2Sats 86% (NRB)

'tight'

wheezes bilaterally

Intubate?Intubate?

Indication?

Page 31: Airway  Management 3

Intubation Indications

Is there a failure of

ventilation or oxygenation?

Page 32: Airway  Management 3

HR 100 BP 105/60

RR 20 GCS 10

O2Sats 100% (PRB)

multiple injuries

transfering to HSC

Indication?

34 yo male

MVA ejected from car

Intubate?Intubate?

Page 33: Airway  Management 3

Intubation Indications

What is the

anticipated clinical course?

Page 34: Airway  Management 3

Intubation Indications

Is there a failure of

airway maintenance or protection?

Is there a failure of

ventilation or oxygenation?

What is the

anticipated clinical course?

Back

Page 35: Airway  Management 3

RSI vs Awake?RSI vs Awake?

Custom Shows

Page 36: Airway  Management 3

Rapid Sequence IntubationRapid Sequence Intubationa potent induction agent

followed immediately by

the patient has not fasted• at risk of aspiration

a rapidly-acting NMB

to induce unconsciousness and motor paralysis for intubation.

Page 37: Airway  Management 3

Rapid Sequence IntubationRapid Sequence Intubation

take nothing that you cannot return or replace

approach every airway as a potential difficult airway

be prepared

Page 38: Airway  Management 3

The 7 P’sThe 7 P’s1. Preparation

2. Preoxygenation

3. Pretreatment

4. Paralysis with induction

5. Positioning with protection

6. Placement with proof

7. Postintubation management

Page 39: Airway  Management 3

Awake IntubationsAwake Intubations

“Awake” means that patient can:

• follow simple instructions

• provide feedback

• can respond to events

• sedation – versed, fentanyl• topical lidocaine• oral, nasotracheal, fiberoptic

Page 40: Airway  Management 3

Paralysis contraindications

Choices… paralyze?Choices… paralyze?

prediction of difficulty

difficult BVM

difficult intubation

lack of equipment

unnecessary

inexperience

Page 41: Airway  Management 3

PreparationPreparationDifficultDifficult AirwaysAirways

Custom Shows

Page 42: Airway  Management 3

STOP IC BARS

S staff, suction

T tube

O oxygen

P pharmacology (meds)

PreparationPreparation

Page 43: Airway  Management 3

PreparationPreparation

I intravenous lines

C connect to monitors

B blades, bougies

A alternate (lightwand)

R rescue (LMA, combitube)

S surgical (cricothyroidotomy)

STOP IC BARS

Back

Page 44: Airway  Management 3

Difficult Mask VentilationDifficult Mask Ventilation

B eard

Page 45: Airway  Management 3

Difficult Mask VentilationDifficult Mask Ventilation

O bese

Page 46: Airway  Management 3

Difficult Mask VentilationDifficult Mask Ventilation

O lderT oothless

Page 47: Airway  Management 3

Difficult Mask VentilationDifficult Mask Ventilation

S nores

Page 48: Airway  Management 3

PreparationPreparationAssessment for Difficult Mask Ventilation

BOOTS

B beard

O obese

O older

T toothless

S snores

Back

Page 49: Airway  Management 3

Difficult Mask VentilationDifficult Mask Ventilation

repositionOP / NP airway2 person change mask? obstruction

Back

Page 50: Airway  Management 3

RepositioningRepositioningOral – Pharyngeal - Laryngeal Axes

Page 51: Airway  Management 3

RepositioningRepositioningHead extended on neck

Page 52: Airway  Management 3

RepositioningRepositioning“Sniffing” position

Page 53: Airway  Management 3

RepositioningRepositioning“Sniffing” with extension

Back

Page 54: Airway  Management 3

PreparationPreparation

Assessment for a difficult intubation

Lemon Law

L look E evaluate (3-3-1 rule)M MallampatiO obstructionN neck mobility

Back

Page 55: Airway  Management 3

3-3-1 Rule3-3-1 Rule

3

3 fingersmouth

opening

1 fingeranterior jaw subluxation

31

3 fingershyomentaldistance

(room for tongue)

Back

Page 56: Airway  Management 3

MallampatiMallampati

Back

Page 57: Airway  Management 3

PreparationPreparationPreoxygenationPreoxygenation

PretreatmentPretreatment

Page 58: Airway  Management 3

PreoxygenationPreoxygenationis the establishment of an is the establishment of an oxygen reservoir.oxygen reservoir.

• “ “no baggingno bagging” principle of RSI” principle of RSI

• “ “apnea timeapnea time” concept” concept

• 100% O100% O22 for 5 minutes for 5 minutes

• effect of body size & metabolic demandseffect of body size & metabolic demands

Page 59: Airway  Management 3

Back

ApneaTime

Page 60: Airway  Management 3

PretreatmentPretreatmentis the administration of drugs is the administration of drugs to mitigate the adverse effects to mitigate the adverse effects associated with intubation.associated with intubation.

L L idocaineidocaineO O piodespiodesA A tropinetropineD D efasciculationefasciculation

Back

Page 61: Airway  Management 3

Induction AgentsInduction Agents

Page 62: Airway  Management 3

Paralysis after inductionParalysis after induction

thiopentalthiopentalketamineketaminepropofolpropofoletomidateetomidateversedversed

succinylcholinesuccinylcholinerocuroniumrocuronium

skip drug section

Page 63: Airway  Management 3

Contraindication: porphyria

ThiopentalThiopentalINDUCTIONINDUCTION

cerebroprotective

potent vasodilator myocardial depressant

Page 64: Airway  Management 3

ThiopentalThiopentalINDUCTIONINDUCTION

Onset: 15 - 30 seconds

Dose: 3 - 5 mg / kg (euvolemic)

1 - 3 mg / kg (hypovolemic)

Duration: 5 - 10 minutes

Back

Page 65: Airway  Management 3

analgesia - amnesia

KetamineKetamineINDUCTIONINDUCTION

bronchodilation

catecholamine release

hypovolemic - hypotensive agent of choice

ICP (significance ?)(cerebroprotective ??)

stimulating effects: laryngeal reflexessecretions

Page 66: Airway  Management 3

KetamineKetamineINDUCTIONINDUCTION

Onset: 15 - 30 seconds

Dose: 1 - 2 mg / kg

Duration: 15 - 30 minutes

lower dose if profound shock:maximal sympathetic stimulation already -ketamine has intrinsic CV depression

Back

Page 67: Airway  Management 3

PropofolPropofolINDUCTIONINDUCTION

dose-dependant sedation - amnesia

no analgesic properties

airway reflexes: dose-dependant depression

potent vasodilator, myocardial depressant(effect may exceed that of thiopental)

cardiac & respiratory depression related to rate of administration as well as dose

cerebroprotective ICPICP CPP

Page 68: Airway  Management 3

Contraindication:Contraindication: egg, soybean allergiesegg, soybean allergies

PropofolPropofolINDUCTIONINDUCTION

Onset:Onset: 30 - 4030 - 40 secondsseconds

1 - 31 - 3 mg / kg mg / kg (induction)(induction)Dose:Dose:

Duration:Duration: 5 - 105 - 10 minutesminutes

Combo: Combo: ketamine 50 mgketamine 50 mgpropofol propofol 50 mg50 mg

Back

Page 69: Airway  Management 3

EtomidateEtomidateINDUCTIONINDUCTION

most hemodynamically stablemost hemodynamically stable

minimal cardiac & respiratory depressionminimal cardiac & respiratory depression

cortisol suppression (cortisol suppression (nono ED cases) ED cases)

myoclonus / hiccupsmyoclonus / hiccups

cerebroprotectivecerebroprotective ICPICP

30% - 40% nausea / vomiting30% - 40% nausea / vomiting

does not block BP response to intubation does not block BP response to intubation

Page 70: Airway  Management 3

Onset:Onset: 20 - 3020 - 30 seconds seconds

Dose:Dose: 0.2 - 0.30.2 - 0.3 mg / kg mg / kg

EtomidateEtomidateINDUCTIONINDUCTION

Duration:Duration: 5 - 155 - 15 minutes minutes

Back

Page 71: Airway  Management 3

NMBNMB

Page 72: Airway  Management 3

Paralysis contraindications

Choices… paralyze?Choices… paralyze?

prediction of difficulty

difficult BVM

difficult intubation

lack of equipment

unnecessary

inexperience

Page 73: Airway  Management 3

SUX contraindications

Choices… SUX or ROC?Choices… SUX or ROC?

difficult BVM or intubation neuromuscular disorders hyperkalemia 24 hours post-burns 7 days post-crush 7 days post-denervation malignant hyperthermia

Page 74: Airway  Management 3

SuccinylcholineSuccinylcholinePARALYSISPARALYSIS

• duration of action is dependant on:• rapid hydrolysis - pseudocholinesterase• diffusion away from motor end plate (no

pseudocholinesterase at end plate)

• only a fraction of dose ever reaches end plate give large doses no harm giving too much problem when incompletely paralyzed give extra 20% (2 mg / kg)

• depolarizing NMB fasciculations

Page 75: Airway  Management 3

Onset: 10 - 15 seconds (fasciculations)

45 - 60 seconds (paralysis)

Dose: 1 - 2 mg / kg (adults) 2 mg / kg (children) 3 mg / kg (newborns)

SuccinylcholineSuccinylcholine

Duration: 3 - 5 minutes (some resps)

8 - 10 minutes (adequate)

PARALYSISPARALYSIS

Page 76: Airway  Management 3

SuccinylcholineSuccinylcholine

Side- Effects

• fasciculations

• hyperkalemia

• bradycardia

• malignant hyperthermia

• prolonged blockade

• trismus - masseter muscle spasm

PARALYSISPARALYSIS

Back

Page 77: Airway  Management 3

SuccinylcholineSuccinylcholine

Fasciculations

• nicotinic receptor stimulation

• inhibiting fasciculations - little evidence

• occurs same time as ICP

PARALYSISPARALYSIS

side-effects

Page 78: Airway  Management 3

SuccinylcholineSuccinylcholine

SUX-induced Hyperkalemia

• under normal situations, increase of:

0.50.5 mEq/L KmEq/L K++

• small risk of dysrythmia: CRF severe acidosis rhabdomyolysis

Preexistent K+

PARALYSISPARALYSIS

Page 79: Airway  Management 3

• increased extrajunctional receptors:

5 - 105 - 10 mEq/L KmEq/L K+ +

prolonged depolarization

refractory to non-depolarizing NMB, may require large doses

SuccinylcholineSuccinylcholine

Exaggerated release of KExaggerated release of K++

PARALYSISPARALYSIS

Page 80: Airway  Management 3

SuccinylcholineSuccinylcholine

Exaggerated release of K+

• functional denervation of muscle: stroke spinal cord injury

• extensive burns

• massive crush injuries

• neuromuscular disorders

PARALYSISPARALYSIS

side-effects

Page 81: Airway  Management 3

SuccinylcholineSuccinylcholinePARALYSISPARALYSIS

Receptor Recruitment & Sensitization

Onset: 7 daysDuration: 2 - 3 months

Crush:

Onset: 7 daysDuration: 6 months

Denervation:

Onset: 24 hoursDuration: 2 years

Burns:

(% burn does not determine response)

Page 82: Airway  Management 3

Neuromuscular disorders:

SuccinylcholineSuccinylcholinePARALYSISPARALYSIS

Receptor Recruitment & Sensitization

SUX contraindicated

If give SUX: intractable cardiac arrest may

occur (even if recognize and treat K+)

side-effects

Page 83: Airway  Management 3

SuccinylcholineSuccinylcholine

Bradycardia

• cardiac muscarinic receptor stimulation

• succinylmonocholine (a metabolite) sensitizessinus node receptors to repeat doses

consider atropine if: age < 10repeating dose

• children have vagal tone

PARALYSISPARALYSIS

side-effects

Page 84: Airway  Management 3

SuccinylcholineSuccinylcholine

Prolonged Neuromuscular BlockadeProlonged Neuromuscular Blockade

• congenital absence of pseudocholinesterase

• presence of an atypical form

may last hours

PARALYSISPARALYSIS

Page 85: Airway  Management 3

• acquired absence:• cocaine• metoclopramide (Maxeran)• CRF• severe liver disease• hypothyroidism• malnutrition• pregnancy• cytotoxic drugs• organophosphates

SuccinylcholineSuccinylcholine

Prolonged Neuromuscular Blockade

PARALYSISPARALYSIS

Page 86: Airway  Management 3

• acquired absence:

• even worst of acquired not reportedto last > 25 minutes

SUX not contraindicated

SuccinylcholineSuccinylcholine

Prolonged Neuromuscular Blockade

PARALYSISPARALYSIS

side-effects

Page 87: Airway  Management 3

• mortality 60%

• onset can be acute or delayed for hours

SuccinylcholineSuccinylcholine

Malignant Hyperthermia

• genetic skeletal muscle abnormality

• can be triggered by: SUX stress vigorous exercise halothane

PARALYSISPARALYSIS

Page 88: Airway  Management 3

• muscle rigidity• autonomic instability• hypotension• hypoxia• severe lactic acidosis• myoglobinemia• DIC• fever - late manifestation

SuccinylcholineSuccinylcholine

Malignant Hyperthermia

PARALYSISPARALYSIS

side-effects

Page 89: Airway  Management 3

• prevents Ca++ release from sarcoplasmic reticulum of skeletal muscle

SuccinylcholineSuccinylcholine

Dantrolene for MH

• essential to resuscitation

• give as soon as Dx suspected

• free of serious side-effects

Dose: 2.5 mg/kg IV q5min until muscle relaxation, or max 4

doses

PARALYSISPARALYSIS

side-effects

Page 90: Airway  Management 3

SuccinylcholineSuccinylcholine

Trismus - Masseter Muscle Spasm

• rise in jaw muscle tension is normal should not affect laryngoscopy

• pretreatment will not prevent

• if severe, or progresses to other muscles: consider malignant hyperthermia spasm is not pathonomonic for MH

• if occurs - administer non-depolarizing NMB (Rocuronium)

PARALYSISPARALYSIS

side-effects

Page 91: Airway  Management 3

RocuroniumRocuronium

• Nondepolarizing, does not stimulate receptor

no fasciculations

PARALYSISPARALYSIS

• minimal hemodynamic effects

• do not need priming dose

Page 92: Airway  Management 3

Dose: 0.6 - 1.2 mg / kg

RocuroniumRocuroniumPARALYSISPARALYSIS

Onset: 60 - 90 seconds

Duration: 30 - 60 minutes

Defasiculating: 0.05 mg / kg

Page 93: Airway  Management 3

Comparing NMBComparing NMBPARALYSISPARALYSIS

SUX ROCONSET 30 - 60 60 - 90 sec

DURATION 3 - 10 20 - 60 min

rapid rapidno primingCVS stability

advantages

precautions K+

Page 94: Airway  Management 3

Comparing NMBComparing NMBPARALYSISPARALYSIS

sec

min

VEC

150 - 180

25 - 30

no histaminerelease

PAN

120 - 180

60 - 90

histaminerelease

ATRA

120 - 150

20 - 35

histaminerelease

Page 95: Airway  Management 3

PositioningPositioningProofProof

Page 96: Airway  Management 3

Positioning with protectionPositioning with protection

You are asked to apply:

cricoid pressure

(Sellick’s maneuver)

Page 97: Airway  Management 3

BURPBURP

B ackwards

U pwards

R ightward

P ressure

• distinct from Sellick’s maneuver• second assistant• first assistant’s other hand

Page 98: Airway  Management 3

ManeuversManeuvers

Back

Page 99: Airway  Management 3

LaryngoscopyLaryngoscopy

Page 100: Airway  Management 3

LaryngoscopyLaryngoscopy

Page 101: Airway  Management 3

LaryngoscopyLaryngoscopy

Page 102: Airway  Management 3

LaryngoscopyLaryngoscopy

Page 103: Airway  Management 3

LaryngoscopyLaryngoscopy

Page 104: Airway  Management 3

Placement with proofPlacement with proof

methods of confirmation

chest riseair entryfogging of ETT60 cc syringe

* capnometer

Page 105: Airway  Management 3

Colorimetric CapnometryColorimetric Capnometry

exhaled CO2

simple color change from

purple to yellow

Page 106: Airway  Management 3

Colorimetric CapnometryColorimetric Capnometry

NEGATIVE POSITIVE

Page 107: Airway  Management 3

Colorimetric CapnometryColorimetric Capnometry

ETCOETCO2 2 < 4 mm Hg< 4 mm Hg

ETT ETT not innot in trachea trachea

inadequate perfusioninadequate perfusion (ineffective CPR)(ineffective CPR)

Page 108: Airway  Management 3

Colorimetric CapnometryColorimetric Capnometry

ETCOETCO2 2 15 - 38 mm Hg15 - 38 mm Hg

ETT ETT inin trachea trachea

Page 109: Airway  Management 3

Colorimetric CapnometryColorimetric Capnometry

ETCOETCO2 2 4 to < 15 mm Hg4 to < 15 mm Hg

retained COretained CO22 in esophagus in esophagus

low perfusionlow perfusion

deliver deliver 66 more breaths more breaths

Page 110: Airway  Management 3

Colorimetric CapnometryColorimetric Capnometry

Standard of CareStandard of Care

Limitations:

Back

• decreased cardiac output

• low metabolic CO2 productionex. hypothermia

Page 111: Airway  Management 3

BougieBougieLightwandLightwand

LMALMA

Page 112: Airway  Management 3

BougieBougie

Page 113: Airway  Management 3

Epiglottis

Page 114: Airway  Management 3

Laryngoscopy GradesLaryngoscopy Grades

CormackLehane

Page 115: Airway  Management 3

Bougie

Page 116: Airway  Management 3

LightwandLightwand

Page 117: Airway  Management 3

LightwandLightwand

Source: Laerdal

Page 118: Airway  Management 3

LightwandLightwand

Source: Laerdal

Page 119: Airway  Management 3

Laryngeal Mask AirwayLaryngeal Mask Airway

Source: LMA North Americaskip insertion technique

Page 120: Airway  Management 3

Laryngeal Mask AirwayLaryngeal Mask Airway

Source: LMA North America

• deflate the cuff deflate the cuff • apply water-soluble lubricant to the apply water-soluble lubricant to the

posterior surfaceposterior surface• place index finger at the junction of the cuffplace index finger at the junction of the cuff

skip insertion technique

Page 121: Airway  Management 3

Laryngeal Mask AirwayLaryngeal Mask Airway

Source: LMA North America

• press the tip of the cuff upward against the hard press the tip of the cuff upward against the hard palate and flatten the cuff against itpalate and flatten the cuff against it

skip insertion technique

Page 122: Airway  Management 3

Laryngeal Mask AirwayLaryngeal Mask Airway

Source: LMA North America

• use the index finger to guide the LMA, use the index finger to guide the LMA, press backward toward the other hand, which press backward toward the other hand, which exerts counter-pressure (do not use force)exerts counter-pressure (do not use force)

skip insertion technique

Page 123: Airway  Management 3

Laryngeal Mask AirwayLaryngeal Mask Airway

Source: LMA North America

• advance the LMA into the hypopharynx until a advance the LMA into the hypopharynx until a definite resistance is felt.definite resistance is felt.

• inflate the cuffinflate the cuff

skip insertion technique

Page 124: Airway  Management 3

7. Postintubation mgmt7. Postintubation mgmt

fix tube in placefix tube in placeCXRCXRnasogastric / orogastric tube / orogastric tubelab lab

etcetc

Back

Page 125: Airway  Management 3

O2 Delivery SystemsO2 Delivery Systems

Page 126: Airway  Management 3

O2 Delivery Systems

Nasal cannulae

Double rate - add to room air FiO2

ex. 3 L / min + 21 % FiO2

= 27 %

Limitations:rates > 3 L / min uncomfortablemouth breathing

Page 127: Airway  Management 3

O2 Delivery Systems

Simple Face Mask

6 – 10 L / min flow

35 – 55 % FiO2

• entrainment of room air through exhalation ports

Page 128: Airway  Management 3

O2 Delivery Systems

PartialRebreathingFace Mask

reservoir bag

• first ~ 1/3 of exhaled gas is directed into bag

(that which was in patient’s upper airway)

• up to 60 % FiO2

Page 129: Airway  Management 3

O2 Delivery Systems

Non-Rebreathing Face Mask

• reservoir bag• one-way valves

• up to 80 % FiO2

(realistically)

Page 130: Airway  Management 3

O2 Delivery Systems

Bag Valve Mask

(BVM)

• up to 100 % FiO2

Page 131: Airway  Management 3

SummarySummary

Page 132: Airway  Management 3

Airway ManagementAirway Management

?? ??

Page 133: Airway  Management 3

eMEDiUMeMEDiUM

Emergency Medicine Emergency Medicine in the U of Min the U of M

emergency.mb.caemergency.mb.ca

Back

Page 134: Airway  Management 3

HSC ED HSC ED

Maryann Cromwell

[email protected]

phone: 787-2934fax: 787-2231

Department of Emergency MedicineHealth Sciences CentreGF 201-800 Sherbrook StreetWinnipeg, MBR3A 1R9

Back

Page 135: Airway  Management 3

CAEP CAEP ACEP ACEP